PCD pharma franchise for Cefpodoxime proxetil and potassium Clavulanate

PCD Pharma Franchise for Cefpodoxime Proxetil and Potassium Clavulanate

Cefpodoxime Proxetil and potassium Clavulanate is an antibiotic combination used to treat a variety of bacterial infections. It is effective against a wide range of bacteria, including those that produce beta-lactamase, an enzyme that breaks down and inactive some antibiotics. 

Uses of Cefpodoxime Proxetil and potassium Clavulanate 

Cefpodoxime Proxetil and Potassium Clavulanate Tablets
Cefpodoxime Proxetil and Potassium Clavulanate

Cefpodoxime Proxetil and potassium Clavulanate are used to treat a wide range of bacterial infections including-: 

  • skin and skin structure infections such as cellulitis, impetigo, abscesses, and pyoderma.
  • Urinary tract infections, acute and uncomplicated cystitis, pyelonephritis. 
  • Bronchitis such as acute and chronic bronchitis.
  • The Pneumonia community-acquired pneumonia, including penicillin-resistant streptococcus pneumoniae(PRSP).
  • Sinusitis Acute sinusitis. 
  • Otitis media acute otitis media.
  • Other infections include sepsis and intra-abdominal infections. (e.g., Cholecystitis, cholangitis. 

Specific uses of Cefpodoxime Proxetil and potassium clavulanate 

Below mentioned are the specific uses of Cefpodoxime Proxetil and potassium clavulanate:

  • Skin and skin structure infections 
  • Cefpodoxime is particularly effective against Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA) strains.
  • Urinary tract infections 

Cefpodoxime is highly active against common urinary pathogens, such as Escherichia Coli, klebsiella spp, and Proteus spp.

  • Respiratory tract infections 

Cefpodoxime is effective against a wide range of pathogens, including streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. 

  • Other infections 

Cefpodoxime is effective against a variety of other bacteria including anaerobic bacteria and gram-negative organisms. 

Dosages 

The usual dosage of Cefpodoxime proxetil and potassium clavulanate is a tablet taken twice a day. The dosage may be adjusted depending on the severity of the infection and the patient’s response to treatment. Cefpodoxime proxetil and potassium Clavulanate should be taken with food to reduce the risk of stomach upset. The tablets should be swallowed whole with a full glass of water. 

The common side effects of cefpodoxime proxetil and potassium Clavulanate include diarrhea, nausea, vomiting, abdominal pain, headache, and skin rash. The serious side effects of this medicine are rare but may include allergic reactions, liver damage, kidney damage, stevens-johnson syndrome, and toxic epidermal necrolysis.  

Scope of investing in PCD pharma franchise 

The scope of investing in a franchise opportunity of a pharma company is immense. The Indian pharmaceutical industry offers profitable business opportunities to its entrepreneurs in the form of PCD pharma franchises. Through this business opportunity, an individual can set up their business venture in the various nooks and corners of the nation. The pharmaceutical industry is flourishing and reaching better heights of success.

PCD pharma franchise company in India 

Casca Remedies Pvt. Ltd. is a PCD pharma franchise company in India. The company is an expert in offering top-quality and flourishing pharma franchise opportunities to its business associates. By investing in a PCD pharma franchise of Casca remedies, the investors can get an opportunity to get the franchise rights of individual and independent businesses.

We never interfere in the working of our franchisee partners, instead, we offer them an exclusive geographical location to establish their pharmaceutical franchise business without any difficulty and facing competition from the internal competitors at the new place.

To get our franchise rights of cefpodoxime proxetil and potassium clavulanate give us a call at +918900000092.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *